BridgeBio Oncology Therapeutics (BBOT) Stock Price & Financial Analysis
BridgeBio Oncology Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About BridgeBio Oncology Therapeutics
What is the current stock price for BBOT?
As of the latest trading session, BBOT stock trades at $8.91. The 52-week range is $8.50–$14.87, with a day range of $8.80–$9.09.
What is the P/E ratio for BBOT?
The P/E ratio (Price-to-Earnings) for BBOT is shown in the Key Statistics section. This valuation metric helps compare BridgeBio Oncology Therapeutics, Inc. to industry peers.
Does BBOT pay dividends?
BridgeBio Oncology Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BBOT?
Based on 9 analysts, the consensus for BBOT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of BBOT?
BridgeBio Oncology Therapeutics's market capitalization is $277.5M, classifying it as a micro-cap company. BridgeBio Oncology Therapeutics operates in the Healthcare sector within the Biotechnology industry.